MedTrace Logo

Comparative Study Evaluating Performance of Celliant Fibers on Tissue Oxygenation

NCT02798640 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 153

Last updated 2016-06-14

No results posted yet for this study

Summary

The study will evaluate changes in transcutaneous oxygen tension (tcPO2,), and the inferred change in local cutaneous blood flow, in healthy subjects wearing a control and a 100% Celliant® fiber upper torso garment.

Conditions

  • Transcutaneous Oxygen Tension

Interventions

DEVICE

Celliant

100% Celliant garment

DEVICE

Control

Control Garment

Sponsors & Collaborators

  • Kristopher Washington

    lead INDUSTRY

Principal Investigators

  • Ian L Gordon, M.D. · University of California Medical Center Wound Clinic

  • Kristopher Washington, B.S. · Hologenix, LLC

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2014-01-31
Completion
2014-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02798640 on ClinicalTrials.gov